Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Progress in Stem Cell Pluripotency
From our January 15 issue: Translational applications of pluripotency are gaining momentum, despite developmental, regulatory, and advocacy challenges.
- The stem cell world finds itself at a critical juncture as the new year begins. That’s the view of Paul Knoepfler, Ph.D., associate professor at the UC Davis School of Medicine. Last month he moderated one of the sessions at the Genetics Policy Institute’s“World Stem Cell Summit.” “The ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.